Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study

Medicine and Dentistry

• Cohort Study 100%
• Methicillin Resistant Staphylococcus Aureus 100%
• Staphylococcal Pneumonia 100%
• Prevalence 63%
• Pathogen 18%
• Odds Ratio 9%
• Patient Population 9%
• Logistic Regression Analysis 9%
• Antibiotic Resistance 9%
• Skin Infection 9%

Pharmacology, Toxicology and Pharmaceutical Science

• Cohort Study 100%
• Methicillin-Resistant Staphylococcus Aureus 100%
• Prevalence 63%
• Infectious Agent 18%
• Antimicrobial Resistance 9%
• Skin Infection 9%
• Lower Respiratory Tract Infection 9%